Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

1-25 of 30 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.
Mattos WLLD, Khalil N, Spencer LG, Bonella F, Folz RJ, Rolf JD, Mogulkoc N, Lancaster LH, Jenkins RG, Lynch DA, Noble PW, Maher TM, Cottin V, Senger S, Horan GS, Greenberg S, Popmihajlov Z
Am J Respir Crit Care Med, 210(4):435-443, 01 Aug 2024
Cited by: 1 article | PMID: 38484130
Add to export list
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial.
Popmihajlov Z, Sutherland DJ, Horan GS, Ghosh A, Lynch DA, Noble PW, Richeldi L, Reiss TF, Greenberg S
BMJ Open Respir Res, 9(1):e001060, 01 Jan 2022
Cited by: 11 articles | PMID: 35058236 | PMCID: PMC8783810
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunogenicity of Inactivated Varicella Zoster Vaccine in Autologous Hematopoietic Stem Cell Transplant Recipients and Patients With Solid or Hematologic Cancer.
Boeckh MJ, Arvin AM, Mullane KM, Camacho LH, Winston DJ, Morrison VA, Hurtado K, Durrand Hall J, Pang L, Su SC, Kaplan SS, Annunziato PW, Popmihajlov Z, V212 Protocol 001 Trial Group and V212 Protocol 011 Trial Group
Open Forum Infect Dis, 7(7):ofaa172, 02 Jun 2020
Cited by: 3 articles | PMID: 32665955 | PMCID: PMC7336559
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
Mullane KM, Morrison VA, Camacho LH, Arvin A, McNeil SA, Durrand J, Campbell B, Su SC, Chan ISF, Parrino J, Kaplan SS, Popmihajlov Z, Annunziato PW, V212 Protocol 011 Trial Team
Lancet Infect Dis, 19(9):1001-1012, 06 Aug 2019
Cited by: 16 articles | PMID: 31399378
Add to export list
The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A, Pang L, Johnson MJ, Caldas Y, Cho A, Tovar-Salazar A, Canniff J, Schmader KE, Popmihajlov Z, Levin MJ
J Virol, 93(15):e00305-19, 17 Jul 2019
Cited by: 17 articles | PMID: 31092579 | PMCID: PMC6639287
Add to export list Free full text in Europe PMC
Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV_IN) trial.
Eriksson J, Hunger M, Bourhis F, Thorén R, Popmihajlov Z, Finelli L, Jiang Y
Expert Rev Pharmacoecon Outcomes Res, 20(6):613-621, 18 Nov 2019
Cited by: 1 article | PMID: 31721601
Add to export list
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
Benson CA, Andersen JW, Macatangay BJC, Mailliard RB, Rinaldo CR, Read S, Bozzolo DR, Purdue L, Jennings C, Keefer MC, Glesby M, Tebas P, Russell AF, Martin J, Annunziato P, Popmihajlov Z, Lennox JL
Clin Infect Dis, 67(11):1712-1719, 01 Nov 2018
Cited by: 16 articles | PMID: 29590326 | PMCID: PMC6233680
Add to export list Free full text in Europe PMC
A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL).
Popmihajlov Z, Pang L, Brown E, Joshi A, Su SC, Kaplan SS, Willis ED
Hum Vaccin Immunother, 14(12):2916-2920, 05 Sep 2018
Cited by: 6 articles | PMID: 30024827 | PMCID: PMC6343633
Add to export list Free full text in Europe PMC
Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine.
Weinberg A, Popmihajlov Z, Schmader KE, Johnson MJ, Caldas Y, Salazar AT, Canniff J, McCarson BJ, Martin J, Pang L, Levin MJ
J Infect Dis, 219(2):335-338, 01 Jan 2019
Cited by: 13 articles | PMID: 30165651
Add to export list
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ, Mullane KM, Cornely OA, Boeckh MJ, Brown JW, Pergam SA, Trociukas I, Žák P, Craig MD, Papanicolaou GA, Velez JD, Panse J, Hurtado K, Fernsler DA, Stek JE, Pang L, Su SC, Zhao Y, Chan ISF, [...] V212 Protocol 001 Trial Team
Lancet, 391(10135):2116-2127, 24 May 2018
Cited by: 41 articles | PMID: 29856344
Add to export list
Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Eberhardson M, Hall S, Papp KA, Sterling TM, Stek JE, Pang L, Zhao Y, Parrino J, Popmihajlov Z
Clin Infect Dis, 65(7):1174-1182, 01 Oct 2017
Cited by: 13 articles | PMID: 29126292
Add to export list
Studies with herpes zoster vaccines in immune compromised patients.
Levin MJ, Bresnitz E, Popmihajlov Z, Weinberg A, Liaw KL, Willis E, Curtis JR
Expert Rev Vaccines, 16(12):1217-1230, 07 Nov 2017
Cited by: 12 articles | PMID: 29053937
Add to export list Review
Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, Halsey NA, Gershon AA
Vaccine, 35(52):7231-7239, 22 Nov 2017
Cited by: 49 articles | PMID: 29174682 | PMCID: PMC5739308
Add to export list Review Free full text in Europe PMC
Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
Levin MJ, Buchwald UK, Gardner J, Martin J, Stek JE, Brown E, Popmihajlov Z
Vaccine, 36(1):179-185, 19 Aug 2017
Cited by: 16 articles | PMID: 28830693
Add to export list
ZOSTER VACCINE LIVE: REVIEW OF POSTMARKETING SAFETY BY DECADE OF LIFE
Willis E, Woodward M, Brown E, Popmihajlov Z
Innov Aging, 1(suppl 1):210-210, 30 Jun 2017
Cited by: 0 articles | PMCID: PMC6242666
Add to export list Free full text in Europe PMC
Immunogenicity of Inactivated Varicella Zoster Vaccine (ZVIN) in Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) Recipients
Boeckh M, Arvin A, Mullane K, Winston D, Brown J, Pergam S, Hurtado K, Pang L, Lee I, Popmihajlov Z, on behalf of the V212 Protocol 001 Study Team
Open Forum Infect Dis, 4(suppl 1):S60-S60, 01 Jan 2017
Cited by: 1 article | PMCID: PMC5632011
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immune Senescence Factors Associated with the Immunogenicity of a Live Attenuated Zoster Vaccine (ZV) in Older Adults
Weinberg A, Schamder K, Johnson M, Popmihajlov Z, Tovar-Salazar A, Caldas Y, Pang L, Cho A, Levin M
Open Forum Infect Dis, 4(suppl 1):S413-S414, 01 Jan 2017
Cited by: 1 article | PMCID: PMC5631485
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
Balazcs E, Sieper J, Bickham K, Mehta A, Frontera N, Stryszak P, Popmihajlov Z, Peloso PM
BMC Musculoskelet Disord, 17(1):426, 13 Oct 2016
Cited by: 11 articles | PMID: 27737664 | PMCID: PMC5062857
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ, Schmader KE, Pang L, Williams-Diaz A, Zerbe G, Canniff J, Johnson MJ, Caldas Y, Cho A, Lang N, Su SC, Parrino J, Popmihajlov Z, Weinberg A
J Infect Dis, 213(1):14-22, 09 Oct 2015
Cited by: 48 articles | PMID: 26452397
Add to export list
Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
Peloso PM, Moore RA, Chen WJ, Lin HY, Gates DF, Straus WL, Popmihajlov Z
Scand J Pain, 13:175-181, 10 Aug 2016
Cited by: 3 articles | PMID: 28850528
Add to export list
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
Bickham K, Kivitz AJ, Mehta A, Frontera N, Shah S, Stryszak P, Popmihajlov Z, Peloso PM
BMC Musculoskelet Disord, 17:331, 08 Aug 2016
Cited by: 9 articles | PMID: 27502582 | PMCID: PMC4977639
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.
Shear NH, Hartmann M, Toledo-Bahena ME, Gilbert M, Katsambas A, Yao R, Popmihajlov Z
Qual Life Res, 25(8):2031-2040, 11 Feb 2016
Cited by: 3 articles | PMID: 26869477
Add to export list
Long-term efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice.
Shear NH, Hartmann M, Toledo-Bahena M, Katsambas A, Connors L, Chang Q, Yao R, Nograles K, Popmihajlov Z, REALITY investigators
Br J Dermatol, 171(3):631-641, 13 Aug 2014
Cited by: 22 articles | PMID: 24673357
Add to export list
Conditional IL-2 Gene Deletion: Consequences for T Cell Proliferation.
Popmihajlov Z, Xu D, Morgan H, Milligan Z, Smith KA
Front Immunol, 3:102, 10 May 2012
Cited by: 24 articles | PMID: 22590468 | PMCID: PMC3349275
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells.
Popmihajlov Z, Santori FR, Gebreselassie D, Sandler AD, Vukmanovic S
Cancer Immunol Immunother, 59(4):629-633, 18 Dec 2009
Cited by: 1 article | PMID: 20020123 | PMCID: PMC11030666
Add to export list Free full text in Europe PMC

1-25 of 30 results

1 2

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Partnerships & funding